Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Tourmaline Bio, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 84
- −11 vs. Q1 2024
- Shares held
- 21.2M
- +613.3K (+3.0%) vs. Q1 2024
- Total value
- $272.0M
- −$197.4M (−42.1%) vs. Q1 2024
- New holders
- 20
- 36 more added
- Sold out
- 31
- 14 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRML on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 134 | $1.03B |
| Q2 2025 | 109 | $384.8M |
| Q1 2025 | 107 | $364.3M |
| Q4 2024 | 101 | $463.6M |
| Q3 2024 | 92 | $540.7M |
| Q2 2024 | 84 | $272.0M |
| Q1 2024 | 96 | $469.9M |
| Q4 2023 | 54 | $338.2M |
| Q3 2023 | 49 | $77.1M |
| Q2 2023 | 58 | $79.7M |
| Q1 2023 | 54 | $50.6M |
| Q4 2022 | 54 | $27.4M |
| Q3 2022 | 56 | $72.1M |
| Q2 2022 | 59 | $130.4M |
| Q1 2022 | 51 | $286.9M |
| Q4 2021 | 51 | $456.7M |
| Q3 2021 | 48 | $349.4M |
| Q2 2021 | 50 | $379.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Tourmaline Bio, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −39,500−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −35,792−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −27,033−100.0% | Sold out |
| Two Seas Capital LP | 0 | $0 | 0.00% | −21,891−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −20,100−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −14,695−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,312−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −13,050−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −5,600−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −357−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,522−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |